FDA Drugs recall ·

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial… recall

Recall number
D-0803-2026
Date
(initiated August 6, 2026)
Company / brand
Mallinckrodt Hospital Products Inc.
440 Us Highway 22 Ste 302, Bridgewater, NJ, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
12367 vials
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Why was it recalled?

Presence of particulate matter: glass and stopper piece

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027

Distribution

USA Nationwide

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0803-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.